Inotiv (STU:BS50) Days Sales Outstanding : 53.13 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Inotiv Days Sales Outstanding?

Inotiv's average Accounts Receivable for the three months ended in Dec. 2023 was €72.3 Mil. Inotiv's Revenue for the three months ended in Dec. 2023 was €124.3 Mil. Hence, Inotiv's Days Sales Outstanding for the three months ended in Dec. 2023 was 53.13.

The historical rank and industry rank for Inotiv's Days Sales Outstanding or its related term are showing as below:

STU:BS50' s Days Sales Outstanding Range Over the Past 10 Years
Min: 31.46 Med: 45.99 Max: 64.2
Current: 45.07

During the past 13 years, Inotiv's highest Days Sales Outstanding was 64.20. The lowest was 31.46. And the median was 45.99.

STU:BS50's Days Sales Outstanding is ranked better than
81.17% of 223 companies
in the Medical Diagnostics & Research industry
Industry Median: 69.51 vs STU:BS50: 45.07

Inotiv's Days Sales Outstanding declined from Dec. 2022 (59.70) to Dec. 2023 (53.13).

Inotiv Days Sales Outstanding Historical Data

The historical data trend for Inotiv's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inotiv Days Sales Outstanding Chart

Inotiv Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Days Sales Outstanding

Get a 7-Day Free Trial

46.34

49.37

64.17

36.02

55.29

Inotiv Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															59.70	39.58	40.68	48.95	53.13

Competitive Comparison of Inotiv's Days Sales Outstanding

For the Diagnostics & Research subindustry, Inotiv's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Inotiv's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Inotiv's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Inotiv's Days Sales Outstanding falls into.

Inotiv Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Inotiv's Days Sales Outstanding for the fiscal year that ended in Sep. 2023 is calculated as

	Days Sales Outstanding (A: Sep. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2022 )	+	Accounts Receivable (A: Sep. 2023 ))	/	count )	/	Revenue (A: Sep. 2023 )	*	Days in Period
=	( (89.756	+	72.728)	/	2 )	/	536.362	*	365
=	81.242					/	536.362	*	365
=	55.29

Inotiv's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (72.728	+	71.959)	/	2 )	/	124.254	*	365 / 4
=	72.3435					/	124.254	*	365 / 4
=	53.13

Inotiv (STU:BS50) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Inotiv Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Inotiv's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Inotiv (STU:BS50) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Inotiv Inc (STU:BS50) » Definitions » Days Sales Outstanding

Comparable Companies

STIM FONR BNR ACRS PRPH VNRX MDXH BDSX BIOQ PSNL TMO DHR IQV XSWX:LONN IDXX A MTD ICLR ILMN WAT

Traded in Other Exchanges

NOTV:USA

Address

2701 Kent Avenue, West Lafayette, IN, USA, 47906

Website

https://www.inotivco.com

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, it supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through the RMS segment, it offers access to a wide range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas. It earns maximum revenue from RMS Segment.

Inotiv (STU:BS50) Headlines

No Headlines